<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.948" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">487</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 435.300 L92.610 435.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="77.103" x="108.343,113.212,117.712,120.214,122.716,127.216,131.716,135.712,139.213,141.715,144.217,148.717,152.713,155.215,159.211,161.704,164.206,168.706,172.702,175.195,177.697,182.197,186.697,191.197,193.699,196.201,200.701,205.201,207.703,212.203,216.199,218.701,221.203,225.199,228.034,231.031,235.027,239.023,241.525,244.018,248.518,251.515,254.017,258.517,262.513,265.015,269.011,271.513,274.015,278.011,282.511,289.513,293.509,298.009" svgx:width="0.61,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To investigate the longitudinal effect of natalizumab </text>
   <text y="88.101" x="62.362,66.862,71.362,73.441,77.437,81.937,85.438,89.938,92.44,96.94,99.442,103.438,105.517,109.513,114.013,118.513,122.509,126.505,131.005,133.507,136.504,140.5,143.002,145.504,150.004,154.504,158.005,160.084,164.584,167.581,169.66,174.16,177.157,181.153,183.655,188.155,190.234,197.236,201.232,203.734,207.73,212.23,216.73,219.232,221.734,224.236,228.232,231.733,233.812,236.314,240.814,242.893,248.896,254.899,262.9,267.904,269.983,274.483,278.479,280.981,283.483,287.479,291.979,294.481,297.982" svgx:width="0.5,0.5,0.25,0.44,0.5,0.39,0.5,0.28,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on absolute concentrations of brain metabolites in RRMS patients </text>
   <text y="99.099" x="62.362,66.862,70.363,72.865,77.365,81.865,84.115,88.615,91.612,96.112,98.614,103.114,107.614,109.864,116.866,120.862,125.362,129.862,133.858,136.36,138.862,142.858,145.108,148.105,152.101,155.602,160.102,164.602,168.598,173.098,177.094,181.09,183.34,186.841,191.341,195.337,199.333,201.835,204.832,209.332,212.833,216.829,221.329,225.829,228.331,232.327,234.577,237.079,244.081,248.077,252.577,255.079,259.579,264.079,266.329,269.326,277.327,283.33,288.334,291.331,294.328" svgx:width="0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.78,0.44,0.5,0.5,0.44,0.28,0.28,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.44,0.5,0.44,0.44,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.39,0.44,0.5,0.5,0.28,0.44,0.25,0.28,0.78,0.44,0.5,0.28,0.5,0.5,0.25,0.33,0.89,0.67,0.56,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">using proton magnetic resonance spectroscopic imaging (MRSI).</text>
   <text y="110.097" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="110.097" x="103.303,107.803,112.303,114.553,116.749,122.752,128.755,136.756,141.76,144.01,146.206,150.706,154.702,157.204,159.706,163.702,168.202,170.704,174.205,176.455,178.651,181.153,185.653,188.155,190.657,193.159,197.155,199.657,202.159,206.659,211.159,213.409,215.605,220.105,224.101,226.603,230.599,233.101,235.603,239.599,244.099,251.101,255.097,259.597,261.847,264.043,266.545,269.542,273.538,277.534,280.036,287.038,291.034,295.534,298.036" svgx:width="0.5,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">25 RRMS patients initiating natalizumab treatment </text>
   <text y="121.095" x="62.362,68.86,72.856,75.853,79.849,82.099,84.286,86.788,91.288,95.284,97.786,102.286,106.786,110.782,115.282,117.532,119.719,123.715,128.215,132.715,134.965,137.152,140.653,144.649,148.645,153.145,157.645,161.641,166.141,168.391,170.578,174.574,179.074,183.07,186.067,190.567,192.817,195.004,198.505,201.007,205.507,207.757,209.944,216.946,221.446,225.946,228.448,232.948,236.449,238.699,240.886,243.883,248.383,251.38,253.63,255.817,260.317,264.817,267.067,269.254,276.256,280.756,285.256,287.758,292.258,295.759,298.009" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.33,0.5,0.25,0.55,0.39,0.28,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were included and scanned every six months for 18 months. </text>
   <text y="132.093" x="62.362,68.365,72.865,77.365,79.867,82.864,87.364,89.866,92.116,92.818,97.318,100.315,104.815,109.315,113.815,117.316,119.566,120.268,122.77,127.27,131.266,133.768,138.268,142.768,146.764,151.264,153.514,154.216,158.716,163.216,165.466,166.168,172.171,178.174,186.175,191.179,193.429,194.131,198.631,202.627,205.129,207.631,211.627,216.127,218.629,222.13,224.38,225.082,231.58,234.082,236.584,241.084,243.334,244.036,247.537,250.039,257.041,259.543,262.045,266.041,269.038,271.288,271.99,276.49,278.992,282.493,286.489,290.485,293.986,297.982" svgx:width="0.67,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Control groups included 18 RRMS patients with similar disease </text>
   <text y="143.091" x="62.362,66.862,71.362,74.359,78.355,80.857,83.359,87.859,92.359,94.609,96.679,100.675,105.175,109.675,111.925,113.995,116.497,120.493,123.994,126.496,130.996,135.496,137.746,139.816,144.316,148.816,151.318,155.818,162.82,166.816,170.317,172.567,174.817,176.887,180.883,185.383,189.883,192.385,194.887,199.387,203.887,206.389,210.889,215.389,217.639,219.709,222.706,227.71,234.208,238.708,240.958,243.028,247.528,250.525,252.775,254.845,261.343,267.346,269.596,271.666,275.662,280.162,284.662,286.912,288.982,293.482,297.982" svgx:width="0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.78,0.44,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.72,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">duration and lesion volumes, continuing IFNb or GA and 12 </text>
   <text y="154.089" x="62.362,66.862,70.858,74.854,77.356,79.858,84.358,88.858,90.883,94.879,99.379,103.879,106.381,109.378,113.878,116.38,119.881,122.131,124.156,131.158,135.154,137.656,141.652,146.152,150.148,154.648,156.673,159.67,164.17,167.167,169.192,173.188,177.688,181.684,183.709,187.705,192.205,196.705,198.73,202.231,206.227,210.727,212.977,215.002,217.999,225.001,228.997,233.497,235.999,240.499,244.999,247.024,249.526,254.026,258.022,260.524,265.024,269.524,273.52,278.02,280.045,283.546,288.046,292.546,295.543,298.045" svgx:width="0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.25,0.78,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.39,0.44,0.5,0.25,0.25,0.33,0.78,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.39,0.5,0.5,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">healthy controls, matched for age and sex. Imaging included short </text>
   <text y="165.087" x="62.362,66.358,70.354,74.854,79.354,82.351,84.853,87.355,94.357,98.353,100.603,102.052,106.552,113.05,116.047,124.048,130.051,135.055,138.052,140.302,141.751,148.249,150.751,153.253,157.753,160.003,161.452,165.448,169.948,173.449,177.949,180.451,184.951,187.453,191.449,193.699,195.148,202.15,206.146,208.648,212.644,217.144,221.644,224.146,226.648,229.15,233.146,235.396,236.845,241.345,245.845,249.841,254.341,256.843,259.345,262.342,264.844,268.84,272.836,275.338,277.84,282.34,286.84,289.09,290.539,295.039,298.036" svgx:width="0.44,0.44,0.5,0.5,0.33,0.28,0.28,0.78,0.44,0.25,0.55,0.5,0.72,0.33,0.89,0.67,0.56,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.39,0.5,0.28,0.5,0.28,0.44,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.55,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">echo-time 2D-MRSI with absolute metabolite quantification of </text>
   <text y="176.085" x="62.362,64.864,71.362,77.86,84.358,86.608,88.858,90.559,93.061,99.064,101.701,103.951,106.201,107.902,111.898,116.398,120.898,123.4,125.902,130.402,134.398,137.395,141.391,145.891,150.391,152.893,156.889,159.391,163.891,166.393,170.893,175.393,177.643,179.344,183.34,187.84,194.842,199.342,203.842,208.342,212.842,217.342,220.843,223.093,224.794,227.791,233.794,238.294,242.794,245.791,248.041,250.291,251.992,258.994,263.494,267.994,270.991,273.493,277.993,282.493,285.994,288.496,290.998,295.498,298.0" svgx:width="0.28,0.72,0.72,0.72,0.25,0.25,0.55,0.28,0.67,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.55,0.33,0.67,0.5,0.5,0.33,0.25,0.25,0.55,0.78,0.5,0.5,0.33,0.28,0.5,0.5,0.39,0.28,0.28,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tNAA, tCr, choline-containing compounds (Cho), myo-inositol </text>
   <text y="187.083" x="62.362,65.359,68.356,72.856,76.357,79.354,81.604,82.99,86.986,91.486,95.986,98.236,99.622,104.122,106.624,111.124,113.626,117.622,124.624,128.62,131.122,135.118,137.368,138.754,141.751,148.249,150.751,155.251,158.248,160.498,162.748,164.134,170.137,174.637,179.137,183.133,187.129,191.629,194.131,197.128,201.124,203.626,206.128,210.628,215.128,218.629,220.879,222.265,228.763,232.759,235.756,239.752,242.002,243.388,247.888,251.884,254.386,258.382,261.379,268.381,270.883,275.383,279.379,283.879,286.129,287.515,290.512,295.012,298.009" svgx:width="0.33,0.33,0.5,0.39,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.28,0.44,0.78,0.44,0.28,0.44,0.25,0.55,0.33,0.72,0.28,0.5,0.33,0.25,0.25,0.55,0.67,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Ins) and glutamate (Glu). Concentrations were determined for </text>
   <text y="198.081" x="62.362,68.86,73.36,77.86,80.362,84.358,86.626,89.623,93.619,98.119,100.621,105.121,109.621,113.122,115.39,119.89,122.887,125.155,127.657,131.653,135.154,137.656,142.156,146.656,150.652,153.154,155.422,161.92,166.42,168.922,171.424,175.42,177.688,184.69,188.686,191.188,193.69,197.686,200.683,202.951,205.948,210.781,219.277,227.278,230.275,232.525,234.793,239.293,243.793,246.79,253.792,257.788,260.29,262.558,266.554,271.054,275.554,279.55,283.546,286.543,289.045,293.545,298.045" svgx:width="0.72,0.5,0.5,0.28,0.44,0.25,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.72,0.5,0.28,0.28,0.44,0.25,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.33,0.61,0.94,0.89,0.33,0.25,0.25,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.44,0.5,0.5,0.44,0.44,0.33,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">whole regions of lesional white matter (LWM), normal appearing </text>
   <text y="209.079" x="62.362,68.86,73.36,75.862,78.364,82.36,84.61,91.612,95.608,98.11,100.612,104.608,107.605,109.855,112.852,119.35,125.128,133.624,141.625,144.622,146.872,150.868,155.368,159.868,162.118,166.618,169.615,173.611,178.111,180.361,187.363,191.359,193.861,196.363,200.359,203.356,205.606,208.603,215.101,223.102,226.099" svgx:width="0.72,0.5,0.28,0.28,0.44,0.25,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.33,0.72,0.72,0.94,0.89,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.44,0.5,0.25,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.33,0.72,0.89,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">white matter (NAWM) and grey matter (GM).</text>
   <text y="220.077" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="220.077" x="95.725,102.223,104.725,107.092,111.592,115.588,119.089,123.085,125.587,128.089,132.589,136.585,138.952,141.454,145.954,148.321,152.821,157.321,159.823,164.323,166.69,171.19,175.186,177.688,180.19,184.186,188.686,191.188,193.555,198.055,201.052,205.552,210.052,214.552,218.053,220.303,222.67,225.172,229.672,236.17,240.166,243.163,245.53,249.526,254.026,258.526,262.522,266.518,271.018,273.52,276.517,280.513,283.015,285.517,290.017,294.517,298.018" svgx:width="0.72,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25,0.28,0.5,0.72,0.44,0.33,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">At baseline in both patient groups, lower concentrations </text>
   <text y="231.075" x="62.362,66.862,69.859,72.685,75.187,81.685,88.183,94.186,97.012,101.008,105.508,110.008,112.834,115.336,121.339,124.336,127.162,133.66,137.656,140.653,144.649,147.475,150.472,154.972,159.472,163.972,168.472,171.298,173.8,178.3,181.126,185.959,194.455,202.456,205.282,209.278,213.778,220.78,225.28,229.276,232.273,236.269,240.769,243.595,246.097,250.597,253.423,259.921,265.699,274.195,282.196,285.022,289.018,293.518,298.018" svgx:width="0.5,0.33,0.25,0.28,0.72,0.72,0.72,0.25,0.44,0.5,0.5,0.25,0.28,0.67,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.61,0.94,0.89,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.72,0.94,0.89,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of tNAA and tCr were found in LWM compared to NAWM and </text>
   <text y="242.073" x="62.362,66.358,70.858,75.358,77.86,80.362,82.864,87.364,91.864,95.86,98.362,100.864,105.364,107.371,109.873,114.373,120.871,124.867,127.864,129.871,136.369,138.871,143.371,145.378,147.88,152.38,154.387,159.22,167.716,175.717,177.724,182.224,185.221,187.228,191.728,195.724,198.226,202.222,204.724,207.226,211.222,215.722,222.724,226.72,231.22,233.227,237.727,241.723,244.225,246.727,250.723,255.223,257.725,261.226,263.476,265.483,268.48,272.98,274.987,279.487,283.483,285.985,289.981,292.483,294.985" svgx:width="0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.72,0.44,0.33,0.25,0.72,0.28,0.5,0.25,0.28,0.5,0.25,0.61,0.94,0.89,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.33,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">additionally lower Glu in LWM of natalizumab patients. In natali-</text>
   <text y="253.071" x="62.362,66.358,70.858,77.86,81.856,86.356,89.002,93.502,97.498,100.0,102.502,106.498,110.998,113.5,117.001,119.647,124.147,128.647,131.149,135.064,137.314,139.96,143.461,145.963,150.463,154.963,157.465,160.462,162.964,166.96,170.956,175.456,177.958,180.604,187.606,191.602,194.104,198.1,202.6,207.1,209.602,212.104,214.606,218.602,221.248,223.75,228.25,232.246,235.243,239.239,243.235,246.736,250.732,254.233,256.879,263.377,267.373,270.37,274.366,277.012,280.009,284.509,289.009,293.509,298.009" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.28,0.5,0.25,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab patients only, significant metabolite increases were found </text>
   <text y="264.069" x="62.362,65.359,69.859,72.856,74.692,79.525,88.021,96.022,97.858,100.36,106.858,113.356,119.359,121.195,124.192,128.692,136.189,138.439,140.275,144.775,149.851,151.687,156.187,158.437,162.937,167.437,171.937,174.934,177.184,179.02,181.522,187.525,190.522,192.358,195.355,199.855,207.352,209.602,211.438,215.938,221.014,225.514,227.764,232.264,236.764,241.264,244.261,246.097,250.093,254.593,259.093,260.929,267.427,269.929,274.429,276.265,279.262,283.762,288.262,295.759,298.009" svgx:width="0.33,0.5,0.33,0.25,0.61,0.94,0.89,0.25,0.28,0.72,0.72,0.72,0.25,0.33,0.5,0.83,0.25,0.25,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.28,0.67,0.33,0.25,0.33,0.5,0.83,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.72,0.28,0.5,0.25,0.33,0.5,0.5,0.83,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for LWM tNAA (7%, p&lt; 0.001), tCr (6%, p=0.042) and Glu (10%, </text>
   <text y="275.067" x="62.362,66.862,71.938,76.438,78.688,83.188,87.688,92.188,95.185,97.435,99.685,101.98,108.478,112.978,115.48,117.982,121.978,124.228,126.523,129.025,133.021,136.522,139.024,143.524,148.024,150.274,152.569,157.069,161.569,164.071,168.571,175.573,179.569,183.07,185.32,187.615,192.115,194.617,199.117,201.367,203.662,208.162,212.662,215.164,217.414,219.709,223.705,228.205,232.201,236.701,241.201,245.197,247.447,249.697,251.992,254.989,259.489,261.739,264.034,267.031,272.035,278.533,283.033,285.535,292.033,298.036" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.78,0.44,0.39,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.33,0.56,0.72,0.5,0.28,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.028), while lesion volumes did not change. In IFNb/GA </text>
   <text y="286.065" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.611,94.861,96.238,100.738,105.238,107.488,108.865,112.366,114.868,119.368,123.868,126.37,129.367,131.869,135.865,139.861,144.361,146.863,149.113,150.49,154.486,158.986,162.982,167.482,171.982,175.978,178.228,179.605,186.103,190.099,193.6,195.85,197.227,204.229,208.225,212.221,215.722,220.222,223.219,227.215,231.715,233.965,235.342,237.844,242.344,244.594,245.971,250.804,259.3,267.301,269.551,270.928,273.925,278.425,281.422,283.672,285.049,289.045,293.545,298.045" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.94,0.89,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients, no significant change was measured in LWM for any </text>
   <text y="297.063" x="62.362,69.364,73.36,75.862,79.858,84.358,88.858,91.36,93.862,96.364,100.36,102.61,104.86,107.02,113.518,118.018,120.52,123.022,127.018,129.268,131.437,133.939,137.935,141.436,143.938,148.438,152.938,155.188,157.348,161.848,166.348,168.85,173.35,180.352,184.348,187.849,190.099,192.268,194.77,199.27,203.266,206.263,210.259,214.255,217.756,221.752,226.252,228.502,230.752,232.912,239.41,245.188,253.684,261.685,263.935,266.095,270.091,274.591,279.091,281.341,283.51,290.008,298.009" svgx:width="0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.78,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.25,0.55,0.72,0.72,0.94,0.89,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">metabolite, while lesion volumes increased. NAWM and GM </text>
   <text y="308.061" x="62.362,69.364,73.36,75.862,79.858,84.358,88.858,91.36,93.862,96.364,100.36,103.024,107.02,111.52,116.02,120.016,124.012,128.512,131.014,134.011,138.007,140.509,143.011,147.511,152.011,155.512,158.176,161.173,165.169,172.171,176.167,178.669,183.169,187.165,191.665,194.329,197.83,200.332,204.328,208.828,211.33,215.326,217.999,220.501,225.001,227.665,232.165,236.665,239.167,243.667,246.34,250.84,254.836,257.338,259.84,263.836,268.336,270.838,273.511,278.011,281.008,285.508,290.008,294.508,298.009" svgx:width="0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">metabolite concentrations remained stable in both patient groups </text>
   <text y="319.059" x="62.362,66.358,70.858,75.358,77.608,80.11,84.61,88.606,90.856,95.356,99.352,103.348,105.85,108.352,112.852,117.352,119.602,123.598,128.098,132.598,135.1,138.097,142.597,145.099,147.349,151.849,154.846,159.346,163.846,168.346" svgx:width="0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and the healthy control group.</text>
   <text y="330.057" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="330.057" x="114.679,121.177,125.677,128.179,132.679,135.487,139.987,143.983,146.485,148.987,152.983,157.483,159.985,163.486,166.294,168.796,171.793,175.789,179.785,182.287,186.283,190.783,193.591,200.089,202.591,205.093,209.593,212.401,216.901,220.897,223.399,227.395,229.897,232.399,236.395,240.895,247.897,251.893,256.393,259.201,262.702,267.202,271.702,278.2,282.196,286.696,289.504,293.5,298.0" svgx:width="0.72,0.5,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Only patients treated with natalizumab showed an </text>
   <text y="341.055" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,91.846,94.096,95.428,97.93,102.43,104.68,106.012,108.514,115.012,121.51,128.008,130.258,132.508,133.84,136.342,142.345,145.342,147.592,148.924,152.92,157.42,161.92,164.17,165.502,172.0,174.502,179.002,181.252,182.584,185.086,189.586,191.836,193.168,195.67,199.666,203.167,205.669,210.169,214.669,218.665,221.167,223.417,224.749,231.247,235.747,238.249,240.751,244.747,246.997,248.329,255.331,259.327,261.829,264.331,268.327,270.829,273.079,275.329,276.499,281.998,286.498,290.494,293.995,297.991" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.72,0.72,0.72,0.25,0.25,0.55,0.28,0.67,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increase in tNAA, tCr and Glu in lesional white matter. These </text>
   <text y="352.053" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,90.352,94.852,99.352,101.629,108.631,112.627,115.129,119.125,123.625,128.125,130.627,133.129,135.631,139.627,141.904,145.9,150.4,154.9,158.896,162.892,167.392,169.894,172.891,176.887,179.389,181.891,186.391,190.891,194.392,196.669,203.671,206.173,210.673,215.173,217.675,219.952,224.452,228.448,230.725,234.721,236.998,240.499,243.001,247.501,252.001,254.278,258.778,261.775,264.052,268.048,272.548,277.048,281.044,285.544,289.54,293.536,298.036" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.28,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.78,0.28,0.5,0.5,0.28,0.25,0.5,0.44,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increasing metabolite concentrations might be a sign of enhanced </text>
   <text y="363.051" x="62.362,66.358,70.858,75.358,79.858,83.854,86.356,88.606,92.836,99.838,103.834,106.336,110.332,114.832,119.332,121.834,124.336,127.837,134.839,137.089,141.319,145.819,150.319,154.315,156.565,160.795,163.297,167.797,170.047,174.277,176.779,181.279,185.275,187.525,191.755,195.751,200.251,202.753,205.255,208.252,210.754,215.254,218.251,220.753,224.749,231.751,238.753,242.749,245.251,249.751,252.748,257.248,259.498,263.728,267.724,270.559,273.556,277.552,281.548,284.05,286.3,290.53,295.03,298.027" svgx:width="0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.39,0.78,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">axonal metabolism due to the anti-inflammatory effect of </text>
   <text y="374.049" x="62.362,66.862,70.858,73.36,77.356,79.858,82.36,86.356,90.856,97.858,101.854,106.354" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab.</text>
   <text y="401.049" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P961</text>
   <text y="412.047" x="62.362,68.86,73.864,78.364,82.36,86.86,90.856,93.853,97.849,101.845,104.347,108.343,112.843,115.84,118.342,122.842,127.846,130.096,134.596,137.593,139.843,146.341,152.839,157.339,161.839,166.843,170.839,173.341,177.841,182.845,185.842,188.092,194.59,201.592,203.842,207.838,211.834,214.336,216.838,220.339,222.589,225.091,230.095,232.345,237.349,241.849,245.845,248.347,250.849,254.845,259.849,267.346,271.846,276.85" svgx:width="0.72,0.56,0.5,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.72,0.72,0.5,0.5,0.56,0.44,0.28,0.5,0.56,0.33,0.25,0.72,0.78,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.56,0.25,0.56,0.5,0.44,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Characterization of CD56bright NK cells in daclizumab </text>
   <text y="423.045" x="62.362,69.364,75.862,81.361,84.358,87.355,91.351,95.347,99.847,102.844,106.84,111.844,114.094,120.592,127.09,135.586,140.59,142.84,147.844,152.344,155.341,157.843,161.839,166.843,169.84" svgx:width="0.78,0.72,0.61,0.33,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25,0.72,0.72,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">HYP-treated RRMS patients</text>
   <text y="434.043" x="62.362,68.86,72.361,74.611,81.109,85.609,89.11" svgx:width="0.72,0.39,0.25,0.72,0.5,0.39,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DJ Huss</text>
   <text y="431.583" x="92.611" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="434.103" x="95.536,97.786,100.036,108.037,113.041,115.291,120.295,123.292,127.288,131.788,136.288,139.789" svgx:width="0.25,0.25,0.89,0.56,0.25,0.56,0.33,0.44,0.5,0.5,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MF Fragoso</text>
   <text y="431.583" x="144.288" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="434.103" x="147.213,149.463,151.713,156.717,158.967,164.97,169.47,171.972,174.474,178.47" svgx:width="0.25,0.25,0.56,0.25,0.67,0.5,0.28,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Cullen</text>
   <text y="431.583" x="182.97" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="434.103" x="185.895,188.145,190.395,196.893,199.143,205.641,208.143,210.645,214.641,217.143,220.14" svgx:width="0.25,0.25,0.72,0.25,0.72,0.28,0.28,0.44,0.28,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Allaire</text>
   <text y="431.583" x="224.136" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="434.103" x="227.061,229.311,231.561,235.062,241.56,243.81,248.814,253.314,257.814,260.316,264.312,268.812,273.312" svgx:width="0.25,0.25,0.39,0.72,0.25,0.56,0.5,0.5,0.28,0.44,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JD Fontenot</text>
   <text y="431.583" x="275.813" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="442.581" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="65.287,70.786,73.288,77.788,82.288,86.284,90.784,93.034,96.031,100.531,104.527,108.523,110.773,113.023,116.02,122.518,129.016,133.516,138.016,142.516,145.018,149.518,154.018,158.014,160.264,165.763,169.759,173.26,177.256,181.756,185.257,189.253,193.753,196.003,198.253,204.256,208.756,215.254,219.754,223.255,225.757,230.257,234.757,238.753,241.003,243.253,250.75,256.249,258.499,260.749,267.247,271.747,274.249,276.751,280.747,285.247" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Immunology Research, Cambridge, MA, United </text>
   <text y="456.101" x="62.362,66.862,69.364,73.864,76.366,80.362,83.863,86.113" svgx:width="0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">States, </text>
   <text y="453.583" x="88.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="456.103" x="91.288,96.787,99.289,103.789,108.289,112.285,116.785,119.035,122.032,126.532,130.528,134.524,136.774,139.024,145.027,149.527,156.025,160.525,165.025,167.527,172.027,174.529,177.031,181.531,186.031,190.531,193.033,195.283,200.782,203.284,207.784,210.286,214.786,219.286,223.282,225.532,230.032,234.532,239.032,241.282,247.78,251.776,256.276,260.776,267.274,269.776,273.772,277.273,279.523" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.61,0.28,0.5,0.28,0.5,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.72,0.44,0.5,0.5,0.72,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Computational Biology and Genomics, </text>
   <text y="467.101" x="62.362,68.365,72.865,79.363,83.863,87.364,89.866,94.366,98.866,102.862,105.112,107.362,114.859,120.358,122.608,124.858,131.356,135.856,138.358,140.86,144.856,149.356,151.606,156.106,158.608,163.108,165.61,169.606" svgx:width="0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Cambridge, MA, United States</text>
   <text y="494.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="494.101" x="117.235,123.733,127.729,131.725,134.227,136.729,140.725,145.225,152.227,156.223,160.723,162.973,165.25,171.748,178.246,182.917,185.167,187.444,190.441,196.939,203.437,209.44,211.69,213.967,220.465,226.963,231.967,234.964,237.214,239.491,241.993,245.494,247.744,250.021,254.017,256.267,258.544,263.044,267.544,274.546,278.542,283.042,285.544,289.54,293.536,298.036" svgx:width="0.72,0.44,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.72,0.72,0.56,0.25,0.55,0.33,0.72,0.72,0.67,0.25,0.55,0.72,0.72,0.56,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Daclizumab HYP (DAC HYP) is a humanized </text>
   <text y="505.099" x="62.362,69.364,73.864,78.364,82.864,86.86,89.362,93.862,98.362,102.358,104.86,107.11,108.487,112.483,116.983,119.485,121.987,126.487,130.987,135.487,139.987,142.237,143.614,146.116,150.616,154.612,157.114,159.364,160.741,165.241,167.743,172.243,176.743,180.244,182.494,183.871,186.373,190.873,194.869,197.119,198.496,202.492,204.994,209.494,213.994,217.99,220.24,221.617,225.613,230.113,234.109,236.611,241.111,243.361,244.738,247.735,253.738,260.236,264.736,269.236,272.233,274.483,275.86,280.36,283.357,285.607,286.984,289.486,293.986,297.982" svgx:width="0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.25,0.55,0.33,0.67,0.72,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">monoclonal antibody that binds the alpha chain (CD25) of the </text>
   <text y="516.097" x="62.362,66.862,69.364,73.864,78.364,80.767,84.763,87.598,90.595,93.097,97.597,100.099,102.601,107.101,109.504,112.501,118.0,120.997,125.497,127.9,130.897,134.893,138.889,142.885,147.385,149.887,154.387,157.384,159.787,163.783,168.283,172.783,175.186,179.686,182.683,186.679,191.179,195.175,199.675,202.177,205.678,208.081,210.583,213.085,216.586,218.989,222.985,226.486,229.987,234.487,238.483,240.985,244.981,247.483,249.985,254.485,258.985,261.388,267.886,270.388,272.89,277.39,279.793,282.79,288.289,291.286,295.786,298.036" svgx:width="0.5,0.28,0.5,0.5,0.25,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.61,0.33,0.5,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.28,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.61,0.33,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">high affinity IL-2 receptor and prevents its association with IL-2. </text>
   <text y="527.095" x="62.362,68.86,75.358,81.361,83.35,89.848,96.346,101.017,103.006,105.508,110.008,114.508,117.01,121.51,124.012,126.514,130.015,132.004,136.504,139.006,143.506,148.006,149.995,153.991,156.826,159.823,162.325,166.825,169.327,171.829,176.329,178.318,181.315,186.814,189.811,194.311,200.314,205.03,208.027,212.527,216.523,221.023,225.019,229.519,234.019,238.015,242.515,245.017,247.006,250.003,255.502,258.499,262.999,264.988,268.489,270.991,275.491,279.991,283.987,286.489,288.991,293.491,297.991" svgx:width="0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25,0.5,0.28,0.5,0.5,0.25,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.61,0.33,0.5,0.67,0.52,0.33,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.33,0.61,0.33,0.5,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DAC HYP inhibits high affinity IL-2Rα-dependent IL-2 signaling </text>
   <text y="538.093" x="62.362,68.86,73.36,75.862,78.364,82.36,84.61,87.697,90.199,94.195,98.191,102.691,105.193,109.693,114.193,116.443,119.53,122.032,126.532,129.034,133.03,136.027,143.029,147.025,151.525,154.027,158.023,160.525,164.521,166.771,169.858,173.854,176.689,179.686,182.188,186.688,189.19,191.692,196.192,198.442,201.529,204.526,210.025,213.022,217.522,223.525,228.106,232.084,234.334,237.421,240.922,243.424,247.924,252.424,256.42,258.922,261.424,265.924,270.424,272.674,275.761,278.263,282.763,285.265,289.261,293.257,295.759,298.009" svgx:width="0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.25,0.55,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.67,0.51,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">while leaving intermediate affinity IL-2Rβγ signaling intact. </text>
   <text y="549.091" x="62.362,68.365,74.863,79.363" svgx:width="0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD56</text>
   <text y="546.583" x="83.863,86.788,88.736,90.362,93.287,96.212" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="549.103" x="97.839,100.62,105.12,109.116,111.618,116.118,119.115,123.111,125.613,128.394,132.894,135.396,137.898,140.4,144.396,147.393,150.174,153.171,159.669,166.167,169.164,171.945,175.941,179.937,182.439,184.941,188.442,191.223,195.219,199.719,204.219,207.216,211.212,214.713,218.214,220.995,223.497,227.997,234.495,237.276,239.778,243.774,248.274,252.27,254.772,258.273,261.054,265.554,268.551,271.332,274.329,279.828,282.825,287.325,293.328,298.044" svgx:width="0.25,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.5,0.28,0.28,0.28,0.44,0.33,0.25,0.33,0.72,0.72,0.33,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.25,0.28,0.5,0.72,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.61,0.33,0.5,0.67,0.52,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> natural killer (NK) cells express low levels of IL-2Rα </text>
   <text y="560.101" x="62.361,66.861,71.361,73.863,75.78,80.28,82.782,87.282,91.782,93.699,96.201,100.197,104.697,108.693,111.195,114.696,116.613,121.113,124.11,126.027,129.024,134.523,137.52,142.02,148.023,152.604,156.582,158.499,162.495,166.995,171.495,173.412,177.408,180.405,184.401,186.318,190.314,194.814,199.314,203.31,207.81,212.31,216.306,220.806,222.723,225.225,229.725,231.642,238.14,244.638,250.641,252.558,259.056,265.554,270.558,273.555,276.057,279.054,283.05,287.046,289.548,293.544,298.044" svgx:width="0.5,0.5,0.28,0.25,0.5,0.28,0.5,0.5,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.61,0.33,0.5,0.67,0.51,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but high levels of IL-2Rβγ and are expanded in DAC HYP-treated </text>
   <text y="571.099" x="62.361,65.358,69.354,71.856,75.852,80.352,83.853,86.355,90.855,95.355,98.352,101.349,105.345,112.347,114.849,117.351,119.853,122.355,126.855,131.355,133.605,136.836,143.838,148.338,150.84,153.342,155.844,160.344,162.846,166.842,169.092,172.323,175.824,179.82,182.322,186.318,189.315,193.815,197.316,199.818,203.319,205.569,208.8,211.797,217.8,223.803,231.804,236.808,239.805,242.055,245.286,249.786,253.782,256.284,258.786,262.782,267.282,269.784,273.285,275.535,277.785,281.016,284.013,286.515,288.765,291.996,294.498,297.999" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.33,0.28,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapsing-remitting multiple sclerosis (RRMS) patients. It is </text>
   <text y="582.097" x="62.361,66.861,71.361,75.861,80.361,82.863,87.363,91.359,94.86,97.362,101.358,105.354,109.854,112.104,113.13,115.632,120.132,124.128,126.63,128.88,129.906,132.408,136.908,140.904,143.154,144.18,146.682,151.182,155.178,158.175,162.171,166.167,169.668,173.664,178.164,180.414,181.44,185.94,190.44,197.442,201.942,205.938,208.935,212.436,214.686,215.712,220.212,223.209,225.459,226.485,232.488,238.986,243.486" svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.78,0.5,0.44,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">hypothesized that the increased numbers of CD56</text>
   <text y="579.583" x="247.993,250.918,252.866,254.492,257.417,260.342" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="582.103" x="261.969,264.219,265.245,271.743,278.241,280.491,281.517,285.513,289.509,292.011,294.513,298.014" svgx:width="0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> NK cells </text>
   <text y="593.101" x="62.367,66.363,70.863,75.363,77.865,80.862,83.364,87.864,92.364,94.866,98.862,100.707,103.209,107.709,109.554,112.056,116.556,120.552,122.397,124.899,129.399,133.395,136.392,140.388,144.888,148.884,153.384,155.886,158.388,162.384,164.229,168.225,171.06,174.057,176.559,180.555,184.551,188.547,193.047,194.892,199.392,202.389,204.234,210.732,217.23,223.233,225.078,231.576,238.074,242.079,244.329,246.174,251.178,254.175,258.171,262.671,265.173,269.673,274.173,277.674,279.519,286.017,290.517,293.514,298.014" svgx:width="0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.25,0.25,0.56,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.72,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">contribute to the therapeutic efficacy of DAC HYP. Previous work </text>
   <text y="604.099" x="62.367,66.867,70.863,74.364,76.614,77.388,80.385,84.381,88.881,93.381,96.378,98.88,102.876,107.376,109.626,110.4,112.902,117.402,121.398,123.9,126.15,126.924,132.927,139.425,143.925" svgx:width="0.5,0.44,0.39,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">has reported that CD56</text>
   <text y="601.583" x="148.414,151.339,153.287,154.914,157.839,160.764" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="604.103" x="162.39,164.64,165.414,171.912,178.41,180.66,181.434,185.43,189.426,191.928,194.43,197.931,200.181,200.955,204.951,208.947,211.449,213.699,214.473,218.469,220.971,223.473,227.973,231.969,234.966,237.216,237.99,240.492,244.992,247.989,252.489,256.989,261.489,265.989,268.239,269.013,271.515,276.015,280.011,282.261,283.035,287.535,290.532,295.032" svgx:width="0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.44,0.44,0.28,0.25,0.55,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> NK cells act either through the pro-</text>
   <text y="615.101" x="62.364,66.864,71.364,75.36,77.862,80.364,84.864,89.364,91.614,92.604,97.104,100.101,102.351,103.341,105.843,112.845,119.847,124.347,128.847,133.347,136.344,140.34,144.84,149.34,151.842,155.838,158.34,162.84,165.837,170.337,172.587,173.577,177.573,182.073,184.575,189.075,193.575,196.077,200.577,204.573,208.074,210.324,211.314,215.814,218.811,221.061,222.051,224.553,229.053,232.05,236.55,241.05,245.55,250.05,252.3,253.29,257.79,260.292,263.289,267.285,271.281,273.783,276.033,277.023,281.019,285.519,288.021,292.521,295.023" svgx:width="0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">duction of immunoregulatory cytokines or through direct cytol-</text>
   <text y="626.099" x="62.364,66.864,69.366,71.868,75.864,78.114,82.11,86.106,88.608,91.11,95.61,98.112,100.614,104.529" svgx:width="0.5,0.28,0.28,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ytic activity.</text>
   <text y="637.097" x="62.364,69.366,74.37,77.367,81.363,85.359,88.356,90.858,95.358,99.354,102.855,105.852" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="637.097" x="110.019,114.888,119.388,121.638,123.555,127.551,132.051,136.047,139.044,143.04,147.036,149.538,153.534,156.531,159.033,163.029,167.025,169.275,171.192,173.694,178.194,182.19,184.44,186.357,188.859,195.861,200.361,204.357,208.353,210.855,213.105,215.022,219.522,222.519,224.769,226.686,232.689,239.187,243.687,248.187,250.437,252.354,256.854,259.356,263.856,267.852,272.352,276.348,280.848,284.844,287.094,289.011,293.511,298.011" svgx:width="0.61,0.5,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.44,0.5,0.44,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To characterize the impact of CD25 blockade on </text>
   <text y="648.095" x="62.364,68.367,74.865,79.365" svgx:width="0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD56</text>
   <text y="645.583" x="83.863,86.788,88.736,90.362,93.287,96.212" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="648.103" x="97.839,99.36,105.858,112.356,113.877,117.873,121.869,124.371,126.873,130.374,131.895,135.891,140.391,144.891,146.412,148.914,153.414,154.935,157.437,161.937,166.437,170.433,173.934,176.436,178.938,183.438,187.434,189.936,193.932,195.453,197.955,202.455,206.451,207.972,211.968,216.468,220.968,223.47,226.467,228.969,233.469,237.969,240.471,242.973,247.473,251.973,253.494,257.994,260.991,262.512,268.515,275.013,279.513" svgx:width="0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> NK cells and to investigate the contribution of CD56</text>
   <text y="645.583" x="284.04,286.965,288.913,290.54,293.465,296.39" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="648.103" x="298.016" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="659.101" x="62.36,68.858,75.356,77.606,81.602,85.598,88.1,90.602,94.103,96.353,98.855,103.355,105.605,108.107,112.607,116.603,118.853,121.355,125.855,129.851,132.848,136.844,141.344,145.34,149.84,152.342,154.844,158.84,161.09,165.086,167.921,170.918,173.42,177.416,181.412,185.408,189.908,192.158,196.658,199.655,201.905,208.403,214.901,220.904,223.154,229.652,236.15,240.155" svgx:width="0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NK cells to the therapeutic efficacy of DAC HYP.</text>
   <text y="670.099" x="62.36,70.856,74.852,77.849,82.853,87.353,92.357,95.858,98.855" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="670.099" x="102.194,108.197,112.193,116.693,121.193,125.189,129.689,131.939,133.028,137.024,140.021,144.521,149.021,153.521,156.518,160.514,164.015,168.011,171.008,175.508,179.504,184.004,186.254,187.343,191.843,195.839,198.836,201.338,205.838,210.338,214.334,217.331,221.327,223.829,226.079,227.168,231.668,234.17,238.67,243.17,247.67,249.92,251.009,258.011,262.511,267.011,271.511,276.011,280.511,284.507,287.009,291.005,295.001,297.998" svgx:width="0.67,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.33,0.5,0.5,0.5,0.33,0.44,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Banked cryopreserved peripheral blood mononuclear </text>
   <text y="681.097" x="62.36,66.356,70.352,72.854,75.356,78.857,81.107,83.663,86.66,91.664,97.667,105.668,111.671,115.172,118.169,120.419,122.984,125.981,128.978,133.478,140.48,142.73,145.286,151.784,158.282,164.285,166.535,169.1,175.598,182.096,187.1,190.097,192.347,194.903,198.899,203.399,207.899,210.149,212.714,217.214,219.716,223.712,227.708,231.704,236.204,240.704,243.701,246.203,249.2,253.196,257.192,259.694,263.69,268.19,270.44,272.996,278.999,285.002,293.003,298.007" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.33,0.56,0.67,0.89,0.67,0.39,0.33,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.72,0.72,0.67,0.25,0.55,0.72,0.72,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells (PBMCs) from DAC HYP- and placebo-treated RRMS </text>
   <text y="692.095" x="62.36,66.86,70.856,73.358,75.86,79.856,84.356,86.858,90.359,93.041,97.037,101.537,104.534,109.034,111.536,114.038,118.034,122.534,125.216,127.718,132.218,134.9,137.402,141.902,145.898,148.58,153.584,159.083,164.582,170.081,176.084,181.421,184.103,188.603,193.103,197.099,200.6,204.596,207.278,210.275,213.272,215.954,219.95,222.452,224.954,229.454,231.956,235.952,239.948,242.45,245.132,247.634,250.631,253.133,257.129,259.631,262.313,268.811,272.807,275.804,279.8,282.482,286.478,290.978,294.974" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.61,0.61,0.61,0.67,0.61,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.33,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients enrolled in the SELECT phase II clinical trial were ana-</text>
   <text y="703.093" x="62.36,64.862,69.362,73.358,77.354,81.854,84.104,86.408,91.412,95.912,99.908,104.408,108.908,111.41,115.91,120.41,122.912,126.908,129.212,133.208,137.708,141.704,144.701,148.697,152.693,155.195,159.191,162.188,164.69,168.686,172.682,175.184,177.686,182.186,186.686,188.99,193.49,196.487,198.791,205.289,211.787,214.091,218.087,222.083,224.585,227.087,230.588,232.892,239.39,243.386,246.887,249.191,253.691,257.687,260.684,263.681,268.181,271.178,278.18,282.176,286.676,288.98,293.48,297.98" svgx:width="0.28,0.5,0.44,0.44,0.5,0.25,0.25,0.56,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lyzed. Phenotypic characterization of NK cells was performed by </text>
   <text y="714.091" x="62.36,65.357,67.859,72.359,78.857,81.107,82.295,86.291,90.791,93.293,97.793,104.795,108.791,111.293,114.29,118.205,120.455,122.705,123.731,128.915,131.912,135.908,140.408,143.909,147.905,150.902,153.404,157.904,160.406,162.908,167.408,171.908,175.904,178.406,180.656,181.844,186.344,189.341,193.841,196.838,199.34,201.842,204.344,208.844,213.344,215.594,216.782,221.282,224.279,226.529,227.717,232.055,238.553,244.556,249.56,251.81,252.998,256.499,260.999,263.996,266.498,269.495,273.995,278.495,281.492,283.994,286.991,289.493,293.489,297.989" svgx:width="0.33,0.28,0.5,0.72,0.25,0.55,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.25,0.55,0.61,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.72,0.67,0.56,0.25,0.55,0.39,0.5,0.33,0.28,0.33,0.5,0.5,0.33,0.28,0.33,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">flow cytometry. Transcriptional profiling of FACS sort-purified </text>
   <text y="725.089" x="62.36,68.858,75.356,78.173,82.169,86.165,88.667,91.169,94.67,97.487,100.988,105.488,109.988,113.489,117.485,119.987,123.488,126.305,129.302,132.299,136.799,143.801,146.618,151.118,154.115,158.111,161.108,163.61,166.607,170.603,174.599,177.101,184.103,188.099,192.599,195.101,197.918,202.418,206.414,209.915,213.911,216.413,218.915,223.415,227.411,230.228,234.224,238.724,243.224,246.041,250.541,255.041,258.542,261.044,264.041,266.543,269.54,273.536,277.532,280.034,287.036,291.032,295.532,298.034" svgx:width="0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.33,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NK cells subsets from pre-treatment baseline and post-treatment </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 281.310 L355.010 281.310 "/>
  <g begin="text">
   <text y="77.112" x="310.016,316.514,320.51,324.506,329.006,331.733,336.233,340.733,343.46,347.456,351.956,356.456,359.183,365.681,369.677,373.673,378.173,380.9,385.4,389.9,392.627,399.125,403.121,406.622,409.349,413.849,417.845,420.842,423.839,428.339,431.336,438.338,442.334,446.834,449.084" svgx:width="0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">week 24 and week 52 was performed. </text>
   <text y="77.112" x="451.811,454.808,459.308,462.035,466.031,468.533,471.035,474.203" svgx:width="0.33,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">In vitro</text>
   <text y="77.112" x="478.703,481.43,484.427,488.927,493.427,497.423,499.925,502.427,506.927,511.427,515.423,517.925,520.652,524.153,526.655,531.155,535.655,538.157,542.153,545.654" svgx:width="0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> functional studies </text>
   <text y="88.11" x="310.016,316.514,320.51,323.507,327.503,329.753,330.437,334.433,338.933,343.433,347.933,352.433,356.429,358.931,362.927,367.427,369.677,370.361,372.863,377.363,379.613,380.297,384.797,388.793,391.295,395.291,398.288,405.29,407.792,412.292,416.288,418.538,419.222,421.724,426.224,430.22,432.47,433.154,437.15,439.985,442.982,446.978,450.974,453.476,456.977,459.227,459.911,464.411,467.408,469.658,470.342,474.842,477.344,481.844,486.344,489.341,491.591,492.275,496.271,500.771,505.271,507.521,508.205,510.707,515.207,517.709,521.705,524.702,531.704,535.7,540.2,542.702" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.78,0.44,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were conducted to determine the effects of high- and intermedi-</text>
   <text y="99.108" x="310.016,314.012,316.514,320.51,323.507,327.503,330.338,333.335,335.837,340.337,342.839,345.341,349.841,352.712,355.709,361.208,364.205,368.705,374.708,377.579,381.08,383.582,388.082,392.582,396.578,399.08,401.582,406.082,410.582,413.453,417.953,422.453,425.324,429.824,434.324,436.826,441.326,444.197,448.697,452.693,456.689,459.191,461.693,466.193,470.693,473.564,478.064,482.564,487.064,491.564,494.561,497.432,503.93,510.428,513.299,517.295,521.291,523.793,526.295,529.796,532.667,536.663,541.163,545.663" svgx:width="0.44,0.28,0.44,0.33,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.61,0.33,0.5,0.67,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ate-affinity IL-2R signaling on both healthy donor NK cells and </text>
   <text y="110.106" x="310.016,316.514,323.012,325.262,329.258,333.254,335.756,338.258,341.759,344.009,347.006,350.003,354.503,361.505,363.755,370.253,376.751,382.754,385.004,391.502,398.0,403.004,406.001,408.503,411.5,415.496,419.492,421.994,425.99,430.49,432.74,438.743,444.746,452.747,457.751,460.001,464.501,468.497,470.999,473.501,477.497,481.997,484.499,488.0" svgx:width="0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NK cells from DAC HYP-treated RRMS patients.</text>
   <text y="121.104" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="121.104" x="342.947,349.445,355.943,361.946,363.881,370.379,376.877,381.881,384.878,387.38,390.377,394.373,398.369,400.871,407.873,411.869,416.369,418.871,420.806,425.306,427.808,430.643,433.64,437.636,440.633,444.629,449.129,451.631,454.133,458.129,460.631,463.133,467.633,469.568,473.564,476.399,479.396,483.392,487.388,489.89,493.886,498.386,500.321,506.819,513.317,515.252,519.248,523.244,525.746,528.248,530.183,533.684,538.184,542.684" svgx:width="0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DAC HYP-treatment differentially affected NK cell sub-</text>
   <text y="132.102" x="310.016,313.517,317.513,320.015,323.516,325.766,328.016,330.194,332.696,337.196,341.192,343.694,348.194,352.694,355.196,359.696,364.196,366.446,368.624,372.62,377.12,381.62,384.617,388.613,392.114,395.615,398.117,402.617,407.117,409.367,411.545,416.045,419.042,421.292,423.47,426.467,431.966,434.963,439.463,445.466,447.716,449.894,453.89,458.39,465.392,469.892,474.392,478.892,482.888,487.388,489.89,493.391,495.641,497.819,501.815,506.315,510.815,513.065,515.243,521.741,528.239,530.489,532.667,536.663,540.659,543.161,545.663" svgx:width="0.39,0.44,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.61,0.33,0.5,0.67,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sets, including expression of IL-2R components and NK cell </text>
   <text y="143.1" x="310.016,313.013,317.009,321.005,325.001,329.501,332.003,336.503,339.5,343.001,345.251,347.501,349.526,357.527,361.523,365.519,370.019,374.015,378.515,381.017,384.518,387.02,389.522,393.518,395.768,397.793,401.294,403.796,408.296,412.796,415.298,419.294,422.795,425.045,427.07,431.57,435.566,442.568,447.068,451.568,455.069,457.571,460.568,464.564,467.066,471.062,475.562,477.812,479.837,483.833,486.083,488.108,492.608,497.108,499.61,504.11,508.61,512.606,514.856,516.881,519.878,524.378,526.88,530.876,533.126,535.151,538.148,542.648,545.645" svgx:width="0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.39,0.25,0.25,0.55,0.89,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.28,0.28,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.55,0.33,0.5,0.28,0.44,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">receptors. Mechanistic studies demonstrated a unique role for </text>
   <text y="154.098" x="310.016,314.516,317.018,321.518,326.018,329.015,333.011,335.846,338.843,341.345,345.845,348.347,350.849,355.349,357.599,358.355,361.352,366.851,369.848,374.348,380.351,385.067,389.648,393.626,395.876,396.632,400.133,402.635,407.135,411.635,415.631,418.133,420.635,425.135,429.635,431.885,432.641,435.143,439.643,441.893,442.649,447.149,450.146,452.648,457.148,459.65,464.15,468.65,470.9,471.656,478.154,486.155,489.152,495.155,500.159,505.163,507.413,508.169,512.165,516.665,521.165,523.415,524.171,527.168,532.172,538.67,541.667,545.645" svgx:width="0.5,0.28,0.5,0.5,0.33,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.67,0.52,0.51,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.72,0.89,0.33,0.67,0.56,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.56,0.72,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">high-affinity IL-2Rαβγ signaling in driving GM-CSF and IFN-γ </text>
   <text y="165.096" x="310.016,314.516,317.513,322.013,326.513,331.013,335.009,337.511,340.013,344.513,349.013,351.263,355.763,360.263,362.513,368.516,375.014,379.514" svgx:width="0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">production by CD56</text>
   <text y="162.592" x="384.013,386.938,388.886,390.513,393.438,396.363" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="165.112" x="397.989,400.239,406.737,413.235,415.485,419.481,423.477,425.979,428.481,431.982" svgx:width="0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> NK cells.</text>
   <text y="176.11" x="310.014,316.512,321.012,326.016,330.012,332.514,337.518,341.019,343.521,348.021,353.025,356.526,359.523" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="176.11" x="361.386,369.162,373.158,375.021,379.521,382.518,387.018,391.518,394.02,398.52,402.516,404.379,408.375,412.875,415.377,419.877,423.873,428.373,432.369,436.365,438.228,440.73,445.23,449.226,451.728,453.591,457.587,462.087,466.587,470.583,475.083,479.583,483.579,488.079,489.942,496.44,502.938,504.801,508.797,512.793,515.295,517.797,519.66,523.161,527.661,532.161,535.662,539.658,542.16,545.661" svgx:width="0.94,0.44,0.25,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We provide evidence that expanded NK cell subsets </text>
   <text y="187.108" x="310.014,312.516,317.016,319.446,325.944,332.442,338.445,340.875,347.373,353.871,358.875,361.872,364.374,367.371,371.367,375.363,377.865,381.861,386.361,388.791,393.291,397.287,399.789,402.291,406.287,410.787,413.289,416.79,419.22,423.72,427.716,432.216,436.212,438.642,443.142,447.138,450.135,452.637,455.139,459.135,461.637,464.139,468.639,471.069,475.569,480.069,484.065,487.062,489.564,493.56,498.06,502.56,505.062,509.562,514.062,516.312,518.742,523.242,527.238,529.74,532.17,536.67,539.172,542.673" svgx:width="0.28,0.5,0.25,0.72,0.72,0.67,0.25,0.72,0.72,0.56,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.5,0.44,0.28,0.25,0.5,0.28,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in DAC HYP-treated patients have partially overlapping, yet dis-</text>
   <text y="198.106" x="310.014,312.516,315.018,319.518,323.514,326.016,328.41,332.91,337.41,341.406,345.906,350.406,352.908,357.408,361.908,364.41,368.406,370.8,374.796,379.296,383.796,386.19,389.187,393.687,398.187,402.183,404.685,407.187,411.687,416.187,420.183,422.685,425.079,429.579,432.576,437.076,440.073,442.575,445.077,449.073,452.574,454.824,457.218,462.222,466.722,469.719,472.221,476.721,480.717,483.714,490.716,495.216,498.213,502.209,504.459,506.853,509.355,513.855,516.249,518.751,523.251,527.247,529.641,533.637,538.137,542.637" svgx:width="0.28,0.28,0.5,0.44,0.28,0.25,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.39,0.25,0.25,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tinct phenotypic and functional profiles. Furthermore, in the con-</text>
   <text y="209.104" x="310.014,312.516,316.512,321.012,323.514,325.764,326.988,331.488,334.485,336.735,337.959,344.457,350.955,356.958,359.208,360.432,366.93,373.428,378.099,380.349,381.573,384.075,387.072,391.068,395.064,397.566,404.568,408.564,413.064,415.566,417.816,420.066,421.29,425.286,429.786,434.286,438.282,442.782,447.282,451.278,455.778,458.028,459.252,465.255,471.753,476.253" svgx:width="0.28,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.72,0.67,0.25,0.55,0.72,0.72,0.56,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">text of DAC HYP treatment, expanded CD56</text>
   <text y="206.592" x="480.778,483.703,485.651,487.277,490.202,493.127" svgx:width="0.5,0.33,0.28,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">bright</text>
   <text y="209.112" x="494.754,497.004,498.228,504.726,511.224,513.4739999999999,514.698,518.694,522.69,525.192,527.694,531.195,533.445,534.669,538.665,541.662,545.658" svgx:width="0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> NK cells are </text>
   <text y="220.11" x="310.02,313.521,318.021,322.017,328.515,332.511,337.011,339.261,341.763,346.263,352.761,356.757,359.754,364.254,366.504,370.5,375.0,377.25,379.752,386.754,393.756,398.256,402.756,407.256,410.253,414.249,418.749,423.249,425.751,429.747,432.249,436.749,439.746,444.246,446.496,450.996,455.496,459.492,463.992,468.492,470.994,475.494,479.994,483.99" svgx:width="0.39,0.5,0.44,0.72,0.44,0.5,0.25,0.28,0.5,0.72,0.44,0.33,0.5,0.25,0.44,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">skewed toward an immunoregulatory phenotype.</text>
   <text y="247.11" x="310.02,315.519,320.019,324.519" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P962</text>
   <text y="258.108" x="310.02,318.516,323.016,328.02,333.024,335.526,340.026,343.023,345.525,350.025,355.029,357.279,361.779,364.776,367.026,371.022,373.524,377.52,381.516,386.52,389.022,393.522,396.519,399.021,404.025,408.525,410.775,417.273,423.771,428.271,432.771,435.768,439.764,444.264,449.268,453.264,457.26,460.761,464.262,466.764,471.768,476.268,478.518,484.521,486.771,490.767,494.763,499.263,504.267,506.769,511.269,514.266,518.766,522.762,527.262" svgx:width="0.94,0.5,0.56,0.56,0.28,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.44,0.28,0.44,0.44,0.56,0.28,0.5,0.33,0.28,0.56,0.5,0.25,0.72,0.72,0.5,0.5,0.33,0.44,0.5,0.56,0.44,0.44,0.39,0.39,0.28,0.56,0.5,0.25,0.67,0.25,0.44,0.44,0.5,0.56,0.28,0.5,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Modulation of circulating CD39-expressing T regulatory </text>
   <text y="269.106" x="310.02,314.016,318.012,320.514,323.016,326.517,328.767,331.764,335.76,340.26,347.757,350.007,358.503,363.507,365.757,370.761,375.261,378.258,380.76,384.756,389.76,392.757,396.258,398.508,403.512,408.012,410.262,413.259,415.761,420.765,425.265,429.765,432.267,434.769,442.266,446.766" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.44,0.5,0.83,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.56,0.5,0.25,0.33,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">cells from MS patients by fingolimod</text>
   <text y="280.104" x="310.02,316.518,318.768,323.268,327.264,331.764,334.014,339.018,343.014,346.515,350.511" svgx:width="0.72,0.25,0.5,0.44,0.5,0.25,0.56,0.44,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">V van Pesch</text>
   <text y="277.592" x="355.006,357.931,359.394" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="280.112" x="362.319,364.569,366.819,373.317,375.567,383.568,388.068,390.57" svgx:width="0.25,0.25,0.72,0.25,0.89,0.5,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Muls</text>
   <text y="277.592" x="394.07" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="280.112" x="396.995,399.245,401.495,407.498,410.999,419.0,421.25,426.254,428.756,433.256,437.756,440.258" svgx:width="0.25,0.25,0.67,0.39,0.89,0.25,0.56,0.28,0.5,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CJM Sindic</text>
   <text y="277.592" x="444.254,447.179,448.641" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="288.59" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="291.112" x="312.941,318.944,321.446,323.948,328.448,330.95,335.45,339.95,343.946,347.447,349.697,356.195,360.695,363.197,367.193,371.189,374.69,378.191,380.693,383.195,387.695,390.197,393.698,397.694,401.195,403.445,407.945,412.445,414.947,419.447,421.949,424.946,429.95,434.45,438.446,440.696,442.946,448.949,452.945,457.445,460.946,465.446,467.948,472.448,476.948,480.944,483.194,485.444,490.943,494.444,498.944,502.445,505.946,509.942,512.444,515.945,518.195" svgx:width="0.67,0.28,0.28,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.28,0.39,0.44,0.39,0.25,0.5,0.5,0.28,0.5,0.28,0.33,0.56,0.5,0.44,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.39,0.5,0.39,0.39,0.44,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Cliniques Universitaires Saint-Luc, Neurology, Brussels, </text>
   <text y="302.11" x="310.016,315.515,319.511,322.013,326.513,329.015,333.515,340.013,342.263" svgx:width="0.61,0.44,0.28,0.5,0.28,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Belgium, </text>
   <text y="299.592" x="344.512" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="302.112" x="347.437,353.935,358.435,360.937,364.933,368.929,372.43,375.931,378.433,380.935,384.931,387.181,393.184,397.684,400.186,404.686,409.186,411.688,414.19,418.69,423.19,427.186,429.436,433.936,437.932,440.182,445.186,449.686,454.186,458.182,462.682,465.185,469.685,471.935,474.185,480.188,484.184,488.684,492.185,496.685,500.681,505.181,509.177,515.674,518.177,521.677,524.18,527.68,531.676" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.67,0.5,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.25,0.5,0.44,0.25,0.56,0.5,0.5,0.44,0.5,0.28,0.5,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.44,0.5,0.44,0.72,0.28,0.39,0.28,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Université Catholique de Louvain, Neurochemistry </text>
   <text y="313.11" x="310.015,316.513,321.013,323.515,326.017,328.267,330.517,333.514,338.014,341.515,344.017,346.519,349.021,353.521,356.023,360.02,362.27,366.77,369.272,371.522,377.525,381.521,386.021,389.522,394.022,397.523,401.519,404.021,408.017,412.517,416.513,420.509,422.759,425.009,430.508,434.009,438.509,442.01,445.511,449.507,452.009,455.51,457.76,460.01,465.509,469.505,472.007,476.507,479.009,483.509" svgx:width="0.72,0.5,0.28,0.28,0.25,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.61,0.39,0.5,0.39,0.39,0.44,0.28,0.39,0.25,0.25,0.61,0.44,0.28,0.5,0.28,0.5,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Unit, Institute of Neuroscience, Brussels, Belgium</text>
   <text y="340.11" x="310.015,316.018,320.518,324.514,329.518,334.018,337.852,342.352,347.356,352.36,357.364,360.361" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="340.11" x="362.62,370.621,375.121,377.623,380.125,382.627,387.127,389.629,393.625,395.884,399.385,403.382,405.884,409.88,412.877,417.377,420.878,423.38,426.881,429.14,432.137,440.138,445.142,448.139,450.398,452.9,456.401,458.66,462.656,464.915,468.911,473.411,476.408,480.908,485.408,487.91,491.906,494.165,498.665,502.661,509.663,514.163,518.159,520.661,523.163,527.663,531.659,534.161,536.663,541.163,545.663" svgx:width="0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.28,0.39,0.25,0.44,0.25,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Multiple sclerosis (MS) is a chronic demyelinating </text>
   <text y="351.108" x="310.015,314.515,317.017,320.518,324.514,328.51,332.011,336.007,338.086,342.586,345.583,347.662,350.164,354.664,358.66,360.74,364.736,368.732,373.232,375.734,378.731,382.727,385.229,387.308,391.808,395.804,398.801,403.301,407.801,412.301,415.802,417.881,421.382,425.882,429.383,431.885,435.881,442.883,444.962,447.959,451.955,455.456,459.956,462.458,464.96,467.462,471.962,476.462,478.541,481.538,484.535,489.035,496.037,498.116,502.112,506.612,508.691,511.193,518.195,522.695,526.691,529.193,533.189,537.689,541.685,545.681" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.5,0.25,0.28,0.78,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease of the central nervous system resulting from an imbalance </text>
   <text y="362.106" x="310.015,314.515,318.511,321.013,327.511,331.507,335.503,340.003,342.253,345.088,349.588,352.585,357.085,360.082,362.584,367.084,370.081,372.583,376.579,383.581,390.583,394.579,397.082,401.582,404.579,409.079,411.329,414.173,418.169,422.669,427.169,429.419,432.263,435.26,439.256,443.756,448.256,450.758,454.754,457.256,461.756,464.753,469.253,471.503,474.338,476.84,483.842,490.844,495.344,499.844,503.84,506.09,508.934,513.434,516.431,520.931,524.927,528.923,532.424,535.924,539.92,543.421,545.671" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between pro-inflammatory and regulatory immune processes. </text>
   <text y="373.104" x="310.015,316.018,322.516,327.016,331.516,333.766,334.9,337.402,340.903,343.153,344.287,348.283,352.783,355.033,356.167,360.163,364.159,366.661,371.161,375.661,380.161,384.157,386.659,390.655,395.155,397.657,400.159,404.659,408.655,412.156,416.152,418.402,419.536,422.039,426.539,430.535,433.037,435.287,436.421,440.417,442.919,446.915,450.911,455.411,459.407,462.908,465.797,471.296,476.795,481.466,483.716,484.85,487.352,491.852,494.741,501.239,509.24,513.911,516.161,517.295,521.291,525.791,530.291,532.541,533.674,538.174,542.17,545.671" svgx:width="0.67,0.72,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.44,0.28,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.28,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.28,0.44,0.44,0.5,0.44,0.39,0.25,0.72,0.61,0.56,0.25,0.55,0.28,0.5,0.25,0.72,0.89,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD39 is an ectonucleotidase that cleaves ATP to AMP and has </text>
   <text y="384.102" x="310.015,314.515,318.511,322.507,327.007,329.059,332.56,337.06,341.56,346.06,350.056,353.557,356.059,360.055,364.555,366.607,370.603,374.104,376.156,380.152,382.204,386.704,391.204,395.704,399.7,402.202,404.254,411.257,415.253,418.25,422.75,426.746,429.743,431.795,434.792,439.292,442.289,444.341,447.338,451.334,455.834,460.334,462.836,466.832,469.334,473.834,476.831,481.331,483.221,488.558,490.61,494.606,498.602,501.104,503.606,507.107,509.159,512.156,517.34,520.337,524.333,528.833,531.83,534.08,535.637,542.135,545.636" svgx:width="0.5,0.44,0.44,0.5,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.44,0.39,0.25,0.44,0.25,0.5,0.5,0.5,0.44,0.28,0.25,0.78,0.44,0.33,0.5,0.44,0.33,0.25,0.33,0.5,0.33,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.61,0.33,0.44,0.5,0.33,0.25,0.25,0.72,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">been suggested as a novel marker for regulatory T cells (Treg). As </text>
   <text y="395.1" x="310.015,315.514,321.013,325.684,327.934,328.888,333.388,337.384,340.885,343.135,344.089,348.589,353.089,360.091,364.087,367.084,371.584,376.084,379.585,381.835,382.789,387.289,390.286,394.786,397.783,400.285,404.785,407.783,410.285,414.281,421.283,428.285,432.281,434.783,439.283,442.28,446.78,449.03,449.984,453.98,456.815,459.812,463.808,467.804,470.306,473.807,476.057,478.307,479.261,481.763,484.265,487.766,490.016,490.97,495.47,499.466,503.966,506.963,510.959,515.459,519.455,521.957,524.459,528.959,533.459,535.709,536.663,541.163,545.663" svgx:width="0.72,0.61,0.56,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.5,0.78,0.44,0.33,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.25,0.55,0.28,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.33,0.44,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ATP has numerous pro-inflammatory effects, its degradation by </text>
   <text y="406.098" x="310.015,316.018,322.516,327.016,331.516,334.198,338.194,342.694,347.194,349.696,354.196,356.887,361.387,365.383,368.065,372.565,376.561,381.061,385.057,388.054,390.556,394.552,397.054,401.05,403.552,405.802,408.484,413.488,415.991,420.491,424.991,429.491,431.993,434.495,441.497,445.997,450.497,452.747,455.429,459.929,463.43,467.426,471.926,474.617,477.614,482.114,485.111,487.793,490.295,494.795,498.791,501.482,503.984,506.981,510.977,514.973,517.475,524.477,528.473,532.973,535.475,538.157,542.657,545.654" svgx:width="0.67,0.72,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.28,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.5,0.39,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD39 could be beneficial. Fingolimod, used for the treatment of </text>
   <text y="417.096" x="310.015,313.012,317.008,319.51,323.506,328.006,331.507,334.009,338.509,343.009,346.006,349.003,352.999,360.001,362.504,365.006,367.508,370.01,374.51,379.01,381.26,382.169,385.166,391.169,397.172,400.169,402.419,403.328,411.329,416.333,418.583,420.833,421.742,424.244,428.744,431.246,435.242,438.239,441.236,445.232,448.229,452.225,455.726,457.976,458.885,465.383,467.885,470.387,474.887,477.137,477.884,483.221,485.471,486.38,490.376,494.372,496.874,499.376,501.626,502.535,506.531,511.031,514.028,518.024,521.525,525.026,527.276,528.185,531.182,534.179,538.679,545.681" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.67,0.67,0.33,0.25,0.55,0.89,0.56,0.25,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.44,0.5,0.33,0.44,0.39,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapsing-remitting (RR) MS, interferes with T cell egress from </text>
   <text y="428.094" x="310.015,312.517,317.017,324.019,328.519,333.019,335.269,339.769,344.269,348.769,352.765,356.266,358.516,360.766,363.763,366.265,369.766,372.016,376.012,378.848,381.845,385.841,389.837,392.339,394.589,399.089,403.589,405.677,410.861,413.858,417.854,422.354,425.855,428.105,430.607,434.108,436.358,440.858,445.358,447.86,452.36,454.61,459.11,463.106,466.103,468.605,471.107,475.103,477.605,480.107,484.607,486.857,491.357,495.353,498.854,502.85,505.847,508.349,512.849,516.845,521.345" svgx:width="0.28,0.5,0.78,0.5,0.5,0.25,0.5,0.5,0.5,0.44,0.39,0.25,0.25,0.33,0.28,0.39,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.61,0.33,0.44,0.5,0.39,0.25,0.28,0.39,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lymph nodes. Its effect on Tregs is only partially described.</text>
   <text y="439.092" x="310.015,317.017,322.021,325.018,329.014,333.01,336.007,338.509,343.009,347.005,350.506,353.503" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="439.092" x="357.139,362.638,367.138,371.134,373.384,374.77,379.27,383.77,386.767,391.267,395.767,399.268,403.264,405.514,406.9,411.4,414.397,416.647,418.033,420.535,425.035,427.537,431.038,433.288,434.674,438.175,440.677,445.177,449.677,454.177,456.427,457.813,464.311,468.307,471.808,474.058,475.444,477.946,482.446,484.696,486.082,490.078,494.578,499.078,501.58,506.08,509.077,513.073,515.323,516.709,523.207,527.707,531.703,534.205,538.705,542.701,545.698" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.5,0.33,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.25,0.55,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The purpose of this study was to explore whether </text>
   <text y="450.09" x="310.015,313.012,317.008,321.508,326.008,328.51,332.506,335.008,339.508,342.505,347.005,349.255,351.532,358.534,362.53,366.526,371.026,375.022,379.522,382.025,385.526,392.528,396.029,398.279,400.556,404.552,407.549,411.545,413.795,416.072,418.574,423.074,427.574,432.074,436.07,440.066,444.566,446.816,449.093,451.595,456.095,458.345,460.622,463.619,466.121,470.621,475.121,479.621,482.123,484.625,491.627,496.127,500.627,503.624,506.126,509.123,513.119,517.115,519.617,523.613,528.113,530.363,532.64,540.641,545.645" svgx:width="0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">regulatory mechanisms are induced in fingolimod-treated MS </text>
   <text y="461.088" x="310.015,314.515,318.511,321.013,323.515,327.511,332.011,334.513,338.014" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients.</text>
   <text y="472.086" x="310.015,318.511,322.507,325.504,330.508,335.008,340.012,343.513,346.51" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="472.086" x="350.704,355.708,359.704,362.701,365.203,369.703,374.203,378.199,381.196,385.192,387.694,389.944,391.888,397.891,400.393,404.893,409.393,413.893,416.143,418.087,426.088,430.588,435.088,439.588,444.088,448.588,452.584,455.086,459.082,463.078,466.076,468.326,470.27,476.272,480.268,482.771,485.273,488.774,491.024,492.968,495.965,500.969,506.972,514.973,520.976,523.973,526.223,528.167,534.664,538.66,541.657,545.653" svgx:width="0.56,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.67,0.28,0.5,0.5,0.5,0.25,0.55,0.89,0.5,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.55,0.67,0.44,0.28,0.28,0.39,0.25,0.55,0.33,0.56,0.67,0.89,0.67,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Peripheral Blood Mononuclear Cells (PBMC) were </text>
   <text y="483.084" x="310.015,314.011,318.511,321.013,323.515,327.511,331.507,334.009,338.005,342.505,345.34,348.337,351.334,355.834,362.836,365.671,370.171,374.167,378.163,380.665,383.168,387.668,392.168,395.003,398.999,403.499,407.999,410.501,413.498,417.998,420.5,424.001,426.836,430.832,435.332,439.832,442.667,448.67,454.673,462.674,467.678,470.513,475.013,479.009,481.511,484.013,488.009,492.509,495.011,498.512,501.347,505.847,509.843,512.84,517.34,520.337,524.333,527.168,530.669,533.171,537.167,540.164,542.666" svgx:width="0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.39,0.28,0.44,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">collected from healthy controls and RRMS patients before start-</text>
   <text y="494.082" x="310.015,312.517,317.017,321.517,323.767,325.009,328.006,330.508,335.008,339.508,344.008,346.51,349.012,356.014,360.514,365.014,367.264,368.507,371.009,375.509,379.505,382.502,386.498,390.998,395.498,397.748,398.99,402.986,407.486,411.986,414.236,415.478,419.978,422.228,423.47,430.472,434.972,439.472,441.974,446.474,449.975,452.225,453.467,457.463,460.46,462.962,466.958,469.955,472.205,473.447,475.949,478.946,482.942,486.938,489.44,496.442,500.438,504.938,507.44,509.69,510.932,513.434,517.934,520.436,522.938,525.44,529.436,531.938,534.44,538.94,543.44,545.69" svgx:width="0.28,0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing fingolimod therapy and 3 months after treatment initiation. </text>
   <text y="505.08" x="310.015,316.513,320.509,323.011,327.511,330.508,334.504,337.006,339.256,340.084,345.268,348.265,352.261,356.761,359.011,360.001,362.998,365.995,369.991,374.491,378.991,382.987,387.487,391.483,395.983,398.233,399.223,405.721,409.717,413.218,415.468,416.458,420.454,423.955,427.456,431.452,434.953,438.454,442.45,446.95,449.2,450.19,454.69,459.19,461.44,462.43,464.932,469.432,473.428,475.678,476.668,481.168,485.668,490.168,494.164,496.666,498.916,499.906,502.408,506.404,510.4,514.901,519.401,521.903,526.403,530.903,534.898,537.148,538.138,542.638,545.635" svgx:width="0.72,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.55,0.61,0.33,0.44,0.5,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.44,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natural Treg frequency was assessed by the novel technique of </text>
   <text y="516.078" x="310.015,317.017,321.013,323.515,328.015,332.515,335.017,339.013,341.515,344.017,348.517,353.017,356.014,359.516,364.016,368.012,372.008,374.51,377.507,380.009,384.005,386.66,391.16,396.164,402.167,408.17,410.825,415.325,418.322,420.977,423.479,427.979,431.975,434.63,437.627,440.129,443.126,446.627,449.129,451.784,454.286,458.786,461.288,464.285,468.785,473.285,475.94,480.44,483.437" svgx:width="0.78,0.44,0.28,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.56,0.67,0.67,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.28,0.5,0.28,0.33,0.5,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">methylation-specific qPCR of the first intron of </text>
   <text y="516.078" x="486.092,491.591,498.089,503.588,509.087" svgx:width="0.61,0.72,0.61,0.61,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">FOXP3</text>
   <text y="516.078" x="513.587,515.837" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">. </text>
   <text y="516.078" x="518.518,524.017,528.013,530.668,534.664,537.166,541.162" svgx:width="0.61,0.44,0.25,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ex vivo</text>
   <text y="516.078" x="545.662" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="527.076" x="310.015,314.011,318.511,321.013,325.513,330.013,332.515,337.015,341.011,343.261,344.053,348.049,352.549,357.049,360.046,364.042,367.543,371.044,373.547,378.047,382.547,384.797,385.589,388.091,392.591,394.841,395.642,400.646,406.648,414.65,420.652,424.154,426.404,427.195,433.693,437.689,441.19,443.44,444.232,448.228,452.728,456.724,459.227,463.727,467.723,471.719,476.219,478.469,479.26,483.76,488.26,490.51,491.302,495.802,500.806,506.809,512.813,515.063" svgx:width="0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.67,0.89,0.67,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.56,0.67,0.67,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytokine expression in PBMCs was analyzed by qPCR. </text>
   <text y="527.076" x="518.114,523.613,527.609,529.859,530.651,534.647,537.149,541.145" svgx:width="0.61,0.44,0.25,0.55,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ex vivo</text>
   <text y="527.076" x="545.645" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="538.074" x="310.015,316.018,322.516,327.016,331.516,333.766,336.286,340.282,344.782,349.282,352.279,356.275,359.776,363.277,365.779,370.279,374.779,377.029,379.549,386.047,390.043,393.544,395.794,398.314,402.31,406.81,410.806,413.308,417.808,421.804,425.8,430.3,432.55,435.07,439.57,444.07,446.32,448.84,451.837,454.339,458.839,465.337,467.587,470.107,474.103,478.603,481.105,485.605,492.607,496.603,499.105,502.102,506.602,508.852,511.372,513.874,518.374,520.624,523.144,529.147,535.645" svgx:width="0.67,0.72,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.72,0.25,0.55,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD39 expression was analyzed by flow cytometry in CD4</text>
   <text y="535.592" x="540.12" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="538.112" x="543.419,545.669" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="549.11" x="310.013,316.016,322.514" svgx:width="0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD8</text>
   <text y="546.592" x="327.017" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="549.112" x="330.316,332.566,334.555,340.558,347.056,351.556" svgx:width="0.25,0.25,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CD19</text>
   <text y="546.592" x="356.055" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="549.112" x="359.354,361.343,365.339,369.335,371.837,374.339,377.84,379.829,383.825,387.326,389.315,395.813,399.809,402.311,404.813,406.802,410.798,414.299,416.288,418.79,423.29,425.279,431.282,437.78" svgx:width="0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.28,0.5,0.25,0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> cells as well as in CD4</text>
   <text y="546.592" x="442.272" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="549.112" x="445.571,450.575,455.075,459.575,464.075" svgx:width="0.56,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Foxp3</text>
   <text y="546.592" x="468.575" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="549.112" x="471.875,477.878,484.376,488.876" svgx:width="0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD25</text>
   <text y="546.592" x="493.375,496.3" svgx:width="0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">hi</text>
   <text y="549.112" x="497.927,499.754,504.938,507.935,511.931,516.431,519.932,522.182,524.171,530.174,536.672,541.172,545.672" svgx:width="0.25,0.61,0.33,0.44,0.5,0.39,0.25,0.25,0.67,0.72,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> Tregs. CD39 </text>
   <text y="560.11" x="310.016,314.012,318.008,320.51,323.012,327.512,330.014,332.516,337.016,339.266,345.764,349.76,353.261,355.511,359.507,363.008,366.509,370.505,374.006,377.507,381.503,386.003,388.253,392.753,397.253,399.008,404.507,410.006,414.677,416.927,419.429,423.929,430.931,433.433,437.933,442.433,449.435,453.431,455.933,458.93,462.845" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.72,0.61,0.56,0.25,0.28,0.5,0.78,0.28,0.5,0.5,0.78,0.44,0.28,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activity was assessed by ATP luminometry.</text>
   <text y="571.108" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="571.108" x="342.911,349.409,353.405,355.907,360.407,363.404,367.4,369.902,371.639,376.823,379.82,383.816,388.316,390.215,393.212,396.209,400.205,404.705,409.205,413.201,417.701,421.697,426.197,428.096,434.594,438.59,442.091,443.99,447.491,449.993,456.995,459.497,461.999,465.995,468.992,470.891,475.391,479.387,481.889,488.387,492.383,496.379,500.879,502.778,510.779,515.783,517.682,522.182,526.178,528.68,531.182,535.178,539.678,542.18,545.681" svgx:width="0.72,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.61,0.33,0.44,0.5,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natural Treg frequency was similar between MS patients </text>
   <text y="582.106" x="310.016,314.012,318.512,323.012,325.262,326.54,331.04,335.036,339.032,341.534,344.036,348.536,353.036,355.286,356.564,360.56,365.06,369.56,372.062,375.059,379.559,382.061,385.562,387.812,390.062,391.34,397.343,399.593,400.871,404.867,408.863,411.365,413.867,416.117,418.367,419.645,425.648,432.146" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.25,0.55,0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and healthy controls. B cell, CD4</text>
   <text y="579.592" x="436.633,439.932" svgx:width="0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+ </text>
   <text y="582.112" x="442.224,447.561,449.811,451.089,455.085,459.081,461.583,464.085,466.335,467.613,471.609,476.109,480.609,482.859,483.975,489.159,492.156,496.152,500.652,502.902,504.18,508.68,511.677,516.177,520.677,525.177,528.174,530.676,533.178,537.678,542.178,545.679" svgx:width="0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.33,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T cell and Treg proportions </text>
   <text y="593.11" x="310.014,316.512,320.508,323.505,327.501,329.841,332.343,336.339,339.174,343.674,347.67,350.172,354.672,357.012,360.009,364.005,368.505,373.005,377.001,380.997,385.497,387.837,392.337,396.837,399.186,402.183,404.685,409.185,413.685,418.185,420.687,423.189,430.191,434.691,439.191,441.441" svgx:width="0.72,0.44,0.33,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were largely reduced by fingolimod. </text>
   <text y="593.11" x="443.799,449.298,453.294,455.634,459.63,462.132,466.128,470.628" svgx:width="0.61,0.44,0.25,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ex vivo </text>
   <text y="593.11" x="472.977,478.98,485.478,489.978,494.478,496.818,503.82,509.823,516.321,522.324,524.673,527.175,531.171,535.671,539.667,542.169,545.67" svgx:width="0.67,0.72,0.5,0.5,0.25,0.78,0.67,0.72,0.72,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD39 mRNA levels </text>
   <text y="604.108" x="310.014,316.512,320.508,323.505,327.501,329.769,334.269,338.769,345.267,349.263,353.763,357.759,360.756,363.024,365.526,370.026,374.022,377.019,381.015,385.011,388.512,392.508,397.008,399.276,401.778,406.278,408.546,416.547,421.551,423.819,428.319,432.315,434.817,437.319,441.315,445.815,448.317,451.818,454.068,456.336,458.838,463.338,465.606,469.602,474.102,481.104,485.604,489.6,492.597,495.099,498.6,503.1,507.6,509.868,512.37,516.87,519.138,523.638,527.634,531.63,534.132,536.634,541.134,545.634" svgx:width="0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were however increased in MS patients, in comparison to healthy </text>
   <text y="615.106" x="310.014,314.01,318.51,323.01,325.512,328.509,333.009,335.511,339.012,341.262,343.683,348.687,351.189,355.689,360.189,364.689,367.191,369.693,376.695,381.195,385.695,388.116,390.618,393.615,397.611,401.607,404.109,411.111,415.107,419.607,422.109,424.53,427.527,432.027,435.024,437.526,442.026,446.022,449.019,451.44,453.942,458.442,462.438,465.435,469.431,473.427,476.928,480.924,485.424,487.845,493.848,500.346,504.846,509.346,511.767,515.763,520.263,524.763,526.689,533.187,539.685,545.688" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.67,0.72,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.72,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">controls. Fingolimod treatment further increased CD39 and AHR </text>
   <text y="626.104" x="310.014,317.016,323.019,329.517,335.52,337.257,339.759,343.755,348.255,352.251,354.753,358.254,359.991,362.493,366.993,368.73,373.734,379.737,387.738,393.741,397.242,399.492,401.229,407.727,412.227,414.729,417.231,421.227,422.964,425.961,431.46,434.457,438.957,443.457,449.955,452.205,453.942,456.939,462.438,465.435,469.935,474.435,476.172,480.168,484.668,489.168,490.905,495.909,502.407,508.905,513.909,518.409,520.146,527.148,533.151,539.649,545.652" svgx:width="0.78,0.67,0.72,0.72,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.28,0.5,0.25,0.56,0.67,0.89,0.67,0.39,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.25,0.33,0.61,0.33,0.5,0.5,0.72,0.25,0.25,0.33,0.61,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.56,0.72,0.72,0.56,0.5,0.25,0.78,0.67,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mRNA levels in PBMCs, while IL-17A, IL-22 and FOXP3 mRNA </text>
   <text y="637.102" x="310.014,316.512,320.508,323.505,327.501,329.751,330.426,333.423,337.419,341.919,346.419,350.415,354.411,358.911,361.161,363.924,369.423,373.923,377.919,380.169,380.844,385.344,388.341,392.841,397.341,401.841,404.838,407.34,409.842,414.342,418.842,421.092,421.767,426.267,429.264,431.514,432.189,438.192,444.69,449.19" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were reduced. The proportion of CD39</text>
   <text y="634.592" x="453.682" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="637.112" x="456.982,459.745,464.929,467.926,471.922,476.422,479.923,482.173,482.848,489.346,493.342,496.843,499.768,502.27,506.77,510.766,513.763,517.759,521.755,525.256,529.252,533.752,536.002,536.677,541.177,545.677" svgx:width="0.25,0.61,0.33,0.44,0.5,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> Tregs was increased by </text>
   <text y="648.11" x="310.012,313.009,315.511,320.011,324.511,329.011,331.513,334.015,341.017,345.517,350.017,352.267,354.184,358.684,363.184,365.686,367.936,369.853,374.353,378.853,381.355,383.605,385.522,390.022,393.019,395.269,397.186,403.189,409.687,414.187" svgx:width="0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fingolimod but not of CD39</text>
   <text y="645.592" x="418.686" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="648.112" x="421.986,427.988,434.486" svgx:width="0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD4</text>
   <text y="645.592" x="438.986" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="648.112" x="442.286,447.29,451.79,456.29,460.79" svgx:width="0.56,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Foxp3</text>
   <text y="645.592" x="465.29" svgx:width="0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">-</text>
   <text y="648.112" x="467.238,469.488,471.243,476.58,478.83,480.747,484.743,488.739,491.241,493.743,497.244,499.494,501.744,503.661,508.665,511.167,515.667,520.167,524.667,527.169,529.671,536.673,541.173,545.673" svgx:width="0.25,0.55,0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> T cells. Fingolimod </text>
   <text y="659.11" x="310.017,313.014,317.01,321.51,326.01,330.006,334.002,338.502,341.058,343.56,348.06,352.056,354.612,359.112,362.109,366.609,371.109,375.609,378.606,381.108,383.61,388.11,392.61,395.166,399.666,402.663,405.219,411.222,417.72,422.22" svgx:width="0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reduced the proportion of CD39</text>
   <text y="656.592" x="426.734" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="659.112" x="430.033,436.036,442.534,447.034" svgx:width="0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD19</text>
   <text y="656.592" x="451.534" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="659.112" x="454.833,457.389,463.392,465.948,469.944,473.94,476.442,478.944,482.445,485.001,488.997,493.497,497.997,500.553,506.556,513.054,517.554" svgx:width="0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> B cells and CD39</text>
   <text y="656.592" x="522.07" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="659.112" x="525.369,531.372,537.87" svgx:width="0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD8</text>
   <text y="656.592" x="542.37" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="659.112" x="545.669" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="670.11" x="310.013,315.35,317.348,321.344,325.34,327.842,330.344,333.845,336.095,337.931,345.707,349.703,351.701,355.697,360.197,364.697,367.199,371.699,373.697,378.197,382.697,385.199,387.197,391.697,395.693,398.195,402.191,406.187,408.689,410.687,415.187,419.687,426.185,430.181,434.681,438.677,441.674,443.672,447.668,452.168,456.668,458.666,462.662,467.162,471.158,475.658,480.158,484.154,486.152,488.654,493.154,495.152,501.155,507.653,512.153,516.653,518.651,522.647,526.643,529.145,531.647,536.147,538.649,541.151,545.651" svgx:width="0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.94,0.44,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.25,0.5,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.67,0.72,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T cells. We could not detect however any change in CD39 activity </text>
   <text y="681.108" x="310.013,313.01,317.51,320.012,322.514,327.014,333.512,336.014,340.514,345.014,347.264,349.766,352.763,356.759,360.755,363.257,370.259,374.255,378.755,381.257,383.507,388.007,392.507,394.757,397.754,400.256,404.756,409.256,413.756,416.258,418.76,425.762,430.262,434.762" svgx:width="0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">following treatment by fingolimod.</text>
   <text y="692.106" x="310.013,316.511,321.011,326.015,330.011,332.513,337.517,341.018,343.52,348.02,353.024,356.525,359.522" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="692.106" x="362.672,367.676,370.178,374.678,379.178,383.678,386.18,388.682,395.684,400.184,404.684,406.934,407.834,412.334,416.834,419.336,421.586,422.486,426.986,431.486,433.988,438.488,440.738,441.638,448.64,452.636,457.136,459.638,463.634,466.136,470.132,473.633,475.883,476.783,482.786,489.284" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.55,0.67,0.72,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod not only mediates CD4</text>
   <text y="689.592" x="493.771" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="692.112" x="497.07,499.32,500.058,505.395,507.645,508.545,512.541,516.537,519.039,521.541,523.791,524.691,527.688,531.684,534.186,538.182,542.682" svgx:width="0.25,0.55,0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> T cell reten-</text>
   <text y="703.11" x="310.014,312.516,315.018,319.518,324.018,326.268,328.518,329.949,334.449,338.949,341.451,343.701,345.132,349.128,351.63,355.131,359.631,361.881,363.312,367.812,371.808,375.804,378.801,382.797,386.793,390.294,394.29,397.791,400.041,401.472,403.974,408.474,412.47,414.72,416.151,420.651,423.648,428.148,432.648,437.148,440.145,442.647,445.149,449.649,454.149,456.399,457.83,462.33,465.327,467.577,469.008,475.011,481.509,486.009" svgx:width="0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.44,0.28,0.39,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion, but also decreases the proportion of CD19</text>
   <text y="700.592" x="490.512" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="703.112" x="493.811,496.061,497.492,501.488,503.99,506.987,510.983,515.483,517.985,521.981,524.483,526.985,531.485,535.985,538.235,539.666,545.669" svgx:width="0.25,0.55,0.44,0.28,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> circulating B </text>
   <text y="714.11" x="310.013,314.009,318.005,320.507,323.009,326.51,328.76,331.01,331.748,334.745,339.245,341.747,345.743,348.74,352.736,356.237,358.739,361.241,365.741,370.241,372.743,376.658,378.908,381.158,381.896,384.398,388.898,392.894,395.144,395.891,400.391,403.388,407.888,412.388,416.888,419.885,422.387,424.889,429.389,433.889,436.139,436.877,441.377,444.374,446.624,447.362,451.358,453.86,456.857,460.853,465.353,467.855,471.851,474.353,476.855,481.355,485.855,488.105,488.843,494.846,501.344,505.844" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.33,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.28,0.5,0.5,0.28,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells. Interestingly, the proportion of circulating CD39</text>
   <text y="711.592" x="510.365" svgx:width="0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">+</text>
   <text y="714.112" x="513.665,516.491,521.675,524.672,528.668,533.168,536.669,538.919,539.657,542.159,545.66" svgx:width="0.25,0.61,0.33,0.44,0.5,0.39,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> Tregs is </text>
   <text y="725.11" x="310.013,313.514,318.014,322.01,326.006,328.508,331.505,334.007,338.003,341.999,344.501,347.003,351.503,353.753,355.94,358.442,362.942,366.938,369.935,373.931,377.927,381.428,385.424,389.924,392.174,394.424,396.449,401.948,406.448,408.95,412.451,414.701,416.888,421.388,425.888,429.389,433.385,436.382,440.882,444.878,447.38,449.882,454.382,458.882,461.132,463.319,467.315,471.815,476.315,478.817,483.317,485.567,487.754,492.254,496.25,500.75,504.746,506.996,509.183,512.18,516.68,521.18,525.176,527.678,530.18,534.68,539.18,543.176,545.678" svgx:width="0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">specifically increased. This observation could have functional </text>
  </g>
 </g>
</svg>
